Nuclera
Nuclera’s mission is to better human health by enabling scientists to easily access the proteins they need for drug discovery research. The Company’s eProtein Discovery™ benchtop System accelerates protein expression and purification optimization in research labs. Applying digital microfluidics alongside in situ protein detection assays and cell-free protein synthesis, eProtein Discovery enables rapid, scalable access to high-quality proteins, supporting both cell-free and cell-based expression methods. The System significantly reduces time and cost of these processes by automating construct screening, protein scale-up, and producing purified proteins in under 48 hours for downstream functional testing. The System accelerates workflows, achieving results in days rather than the months required by traditional cell-based methods. Founded in 2013, Nuclera’s offices are located in Cambridge (UK) and Boston (US).Content by Nuclera
Discover approaches that shorten the path from DNA constructs to purified, functional proteins.
Available on Demand
Discover a new path to rapid expression of complex proteins using cell-free protein synthesis and digital microfluidics.
Explore a streamlined approach to protein expression and purification that dramatically reduces timelines and experimental bottlenecks.
| 5 min read
Cell-free expression systems are transforming membrane protein research by enabling faster, more reliable access to functional proteins for drug discovery applications.
| 2 min read
Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions
Page 1 of 1 - 5 Total Items
